Australia markets closed

Cadrenal Therapeutics, Inc. (CVKD)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
7.61+0.22 (+3.04%)
At close: 04:00PM EDT
7.67 +0.06 (+0.72%)
After hours: 06:39PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
Total revenue
0
0
Operating expenses
Research development
2,488
4,081
Selling general and administrative
4,139
3,550
Total operating expenses
6,629
7,633
Operating income or loss
-6,629
-7,633
Interest expense
0
17.101
Total other income/expenses net
-
-956.234
Income before tax
-6,237
-8,357
Income from continuing operations
-6,237
-8,357
Net income
-6,237
-8,357
Net income available to common shareholders
-6,237
-8,357
Basic EPS
-0.62
-0.62
Diluted EPS
-0.62
-0.62
Basic average shares
13,023
13,492
Diluted average shares
13,023
13,492